Equity Overview
Price & Market Data
Price: $33.50
Daily Change: +$0.15 / 0.45%
Daily Range: $32.24 - $34.98
Market Cap: $3,512,022,016
Daily Volume: 2,382,770
Performance Metrics
1 Week: -5.51%
1 Month: 10.99%
3 Months: 47.01%
6 Months: 19.35%
1 Year: 28.43%
YTD: 26.15%
Company Details
Employees: 81
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.